NCT05853185View on ClinicalTrials.gov

Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy.

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

May 30, 2022

Study Completion Date

August 30, 2022

Conditions
Pulpitis - Irreversible
Interventions
DRUG

Pro Root MTA®

Patients in this group will receive the pulpotomy with Pro Root MTA®.

DRUG

EBRRM®

Patients in this group will receive the pulpotomy with Endo Sequence Bioceramic Root Repair (EBRRM)®.

Trial Locations (1)

Unknown

Liaquat University of Medical and Health Sciences, Jāmshoro

All Listed Sponsors
lead

Liaquat University of Medical & Health Sciences

OTHER

NCT05853185 - Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy. | Biotech Hunter | Biotech Hunter